The cannabis company in continuous collaboration with Intercure is collaborating with Cookies to open points of sale in Austria and the UK in early 2022
The Cannabis Company Reports expansion of activity in the European market through the partnership with the cannabis brand Cookies. The companies have signed a multi-year agreement under which Intercure is set to set up cookie shops as well as pharmacies to sell medical cannabis in Austria and the UK in early 2022, subject to local regulations.
“As we focus on new territories, it is vital that our customers be assured that the quality in which cookies are known is maintained, a value we share with Intercure,” said Parker Burling, President of Cookies. “We look forward to reaching customers in Austria and the UK and establishing Cookies as a key company in each of the communities.”
Intercure, the exclusive partner of Cookies, already grows, manufactures and distributes the products of cookies that meet the GMP standard in Israel through the company’s leading pharmacy chain – Givol. Intercure will leverage its international supply chain to serve the growing community of medical cannabis patients in Europe.
“Cookies is one of the best-known cannabis brands in the world today,” said Alexander Rabinovich, CEO of Intercure. “With our joint success in Israel, it is natural for us to expand our operations to Europe by implementing our winning business model. “As European markets develop and regulation continues to support cannabis companies, we look forward to expanding into new territories and providing customers with the highest quality medical cannabis products.”